Evidence map›Paper›PMID 38051583›Full record

ArticleJCI insight2024

IL-13 promotes functional recovery after myocardial infarction via direct signaling to macrophages.

Santiago Alvarez-Argote, Samantha J Paddock, Michael A Flinn, Caelan W Moreno, Makenna C Knas, Victor A Almeida, Sydney L Buday, Amirala Bakhshian Nik, Michaela Patterson, Yi-Guang Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Macrophage Efferocytosis in Heart.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Immunometabolism in heart failure.Nature reviews. Cardiology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Global IL4Rα blockade exacerbates heart failure after an ischemic event in mice and humans.American journal of physiology. Heart and circulatory physiology · 2024
    Observational
  15. Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts.International journal of chronic obstructive pulmonary disease · 2024
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 3 countries.

Santiago Alvarez-ArgoteDepartment of Physiology.
Samantha J PaddockDepartment of Physiology.
Michael A FlinnDepartment of Physiology.
Caelan W MorenoDepartment of Physiology.
Makenna C KnasDepartment of Physiology.
Victor A AlmeidaDepartment of Physiology.
Sydney L BudayDepartment of Physiology.
Amirala Bakhshian NikDepartment of Physiology.
Michaela PattersonCardiovascular Research Center.
Yi-Guang ChenDepartment of Pediatrics.
Chien-Wei LinDepartment of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Caitlin C O'MearaDepartment of Physiology.
Medical College of Wisconsin · US

Funding

Training in Signature Transdisciplinary Cardiovascular SciencesT32HL134643 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Justin L Grobe, Jacquelyn P Kulinski · 2017 to 2026
$4.2M
Genetic interactions and multifactorial genetics mediate myocardial regenerationR01HL155085 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI PATTERSON, MICHAELA · 2021 to 2025
$2.5M
IL13 - A Novel Therapeutic Factor for Cardiac RegenerationR01HL141159 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI O'MEARA, CAITLIN C · 2019 to 2023
$2.1M
VisualSonics Vevo 3100 High-Frequency Ultrasound Imaging SystemS10OD025038 · OD · MEDICAL COLLEGE OF WISCONSIN · PI AUCHAMPACH, JOHN A · 2019 to 2019
$302k
The fibrogenic role of Hippo-Yap signaling following ischemic injuryF32HL150958 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI FLINN, MICHAEL A · 2020 to 2023
$161k
Promoting Cardiomyocyte Cell Cycle Activity and Cardiac Regeneration through IL13 SignalingF31HL150919 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI PADDOCK, SAMANTHA J · 2020 to 2021
$60k
NHLBI NIH HHS F31 HL150919NHLBI NIH HHS F32 HL150958NHLBI NIH HHS R01 HL141159NHLBI NIH HHS R01 HL155085NHLBI NIH HHS T32 HL134643NIH HHS S10 OD025038
6 · The paper itself

Abstract

There is great interest in identifying signaling pathways that promote cardiac repair after myocardial infarction (MI). Prior studies suggest a beneficial role for IL-13 signaling in neonatal heart regeneration; however, the cell types mediating cardiac regeneration and the extent of IL-13 signaling in the adult heart after injury are unknown. We identified an abundant source of IL-13 and the related cytokine, IL-4, in neonatal cardiac type 2 innate lymphoid cells, but this phenomenon declined precipitously in adult hearts. Moreover, IL-13 receptor deletion in macrophages impaired cardiac function and resulted in larger scars early after neonatal MI. By using a combination of recombinant IL-13 administration and cell-specific IL-13 receptor genetic deletion models, we found that IL-13 signaling specifically to macrophages mediated cardiac functional recovery after MI in adult mice. Single transcriptomics revealed a subpopulation of cardiac macrophages in response to IL-13 administration. These IL-13-induced macrophages were highly efferocytotic and were identified by high IL-1R2 expression. Collectively, we elucidated a strongly proreparative role for IL-13 signaling directly to macrophages following cardiac injury. While this pathway is active in proregenerative neonatal stages, reactivation of macrophage IL-13 signaling is required to promote cardiac functional recovery in adults.

Indexed as

Interleukin-13Myocardial InfarctionAnimalsImmunity, InnateLymphocytesMacrophagesMiceReceptors, Interleukin-13Interleukin-13Receptors, Interleukin-13CardiologyCytokinesHeart failureMacrophages

Identifiers

PMID38051583
PMCPMC10906228
OpenAlexW4389334446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.